Full Text
The Full Text of this article is available as a PDF (652.7 KB).
References
- 1.Greig N.H., Genka S., Rapoport S.I. Delivery of vital drugs to the brain for the treatment of brain tumours. J Control Release. 1990;11:61–78. doi: 10.1016/0168-3659(90)90121-9. [DOI] [Google Scholar]
- 2.Illum L. Nasal drug delivery — possibilities, problems and solutions. J Control Release. 2003;87:187–198. doi: 10.1016/S0168-3659(02)00363-2. [DOI] [PubMed] [Google Scholar]
- 3.Illum L. Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci. 2000;11:1–18. doi: 10.1016/S0928-0987(00)00087-7. [DOI] [PubMed] [Google Scholar]
- 4.Mathison S., Nagilla R., Kompella U.B. Nasal route for direct delivery of solutes to the central nervous system: fact or fiction? J Drug Target. 1998;5:415–441. doi: 10.3109/10611869808997870. [DOI] [PubMed] [Google Scholar]
- 5.Thorne R.G., Frey W.H., 2nd Delivery of neurotrophic factors to the central nervous system: Pharmacokinetic considerations. Clin Pharmacokinet. 2001;40:907–946. doi: 10.2165/00003088-200140120-00003. [DOI] [PubMed] [Google Scholar]
- 6.Thorne R.G., Emory C.R., Ala T.A., Frey W.H., 2nd Quantitative analysis of the olfactory pathway for drug delivery to brain. Brain Res. 1995;692:278–282. doi: 10.1016/0006-8993(95)00637-6. [DOI] [PubMed] [Google Scholar]
- 7.Chen X.Q., Fawcett J.R., Rahman Y.E., Ala T.A., Frey W.H. Delivery of nerve growth factor to the brain via the olfactory pathway. J Alzheimers Dis. 1998;1:35–44. doi: 10.3233/jad-1998-1102. [DOI] [PubMed] [Google Scholar]
- 8.Frey W.H., Thorne R.G., Pronk G. Delivery of Insulin like growth factor-1 to the brain and spinal cord along olfactory and trigeminal pathways following intranasal administration: a noninvasive method for bypassing the blood brain barrier. Soc Neurosci Abstract. 2000;26:1365–1370. doi: 10.1016/j.neuroscience.2004.05.029. [DOI] [PubMed] [Google Scholar]
- 9.Zaki N.M., Awad G.A., Mortada N.D., Abd Elhady S.S. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sci. 2007;32(4–5):296–307. doi: 10.1016/j.ejps.2007.08.006. [DOI] [PubMed] [Google Scholar]
- 10.Schipper N.G.M., Verhoef J.C., Merkus F.W.H.M. Methylated beta-cyclodextrin is able to improve the nasal and intramuscular administration of salmon calcitonin. Calcif Tissue Int. 1995;56:280–282. doi: 10.1007/BF00318047. [DOI] [PubMed] [Google Scholar]
- 11.Kaliner M.A. A novel and effective approach to treating rhinitis with nasal anthistamines. Ann Allergy Asthama Immunol. 2007;99(5):383–390. doi: 10.1016/S1081-1206(10)60560-1. [DOI] [PubMed] [Google Scholar]
- 12.Oh Y.K., Kim J.P., Hwang T.S., Ko J.J., Kim J.M., Yang J.S. Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery. Vaccine. 2001;19:4519–4525. doi: 10.1016/S0264-410X(01)00188-8. [DOI] [PubMed] [Google Scholar]
- 13.Varshosaz J., Sardai H., Heidari A. Nasal delivery of insulin using bioadhesive chitosan gels. Drug Deliv. 2006;13(1):31–38. doi: 10.1080/10717540500309040. [DOI] [PubMed] [Google Scholar]
- 14.Al-Ghananeem A.M., Traboulsi A.A., Dittert L.W., Hussain A.A. Targeted brain delivery of 17β-estradiol via nasally administered water soluble prodrugs. AAPS Pharm Sci Tech. 2002;3:1–8. doi: 10.1208/pt030105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Talegaonkar S., Mishra P.R. Intranasal delivery: An approach to bypass the blood brain barrier. Indian J Pharmacol. 2004;36:140–47. [Google Scholar]